{"nctId":"NCT00313716","briefTitle":"Effects of Erythropoietin on Cerebral Vascular Dysfunction and Anemia in Traumatic Brain Injury","startDateStruct":{"date":"2006-04"},"conditions":["Anemia","Traumatic Brain Injury"],"count":200,"armGroups":[{"label":"Epo1 and TT10","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: recombinant human erythropoietin, rhEpo"]},{"label":"Epo1 and TT7","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: recombinant human erythropoietin, rhEpo"]},{"label":"Epo2 and TT10","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: recombinant human erythropoietin, rhEpo"]},{"label":"Epo2 and TT7","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: recombinant human erythropoietin, rhEpo"]},{"label":"Placebo and TT10","type":"PLACEBO_COMPARATOR","interventionNames":["Other: placebo"]},{"label":"Placebo and TT7","type":"PLACEBO_COMPARATOR","interventionNames":["Other: placebo"]}],"interventions":[{"name":"recombinant human erythropoietin, rhEpo","otherNames":[]},{"name":"placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Blunt trauma mechanism of brain injury\n* Glasgow Coma Score - motor component â‰¤ 5 (not following commands) on the post-resuscitation neurologic exam\n* Available for enrollment and administration of study drug within 6 hours of injury\n\nExclusion Criteria:\n\n* Penetrating trauma (i.e. gun shot wounds)\n* Glasgow Coma Score = 3 and bilateral fixed and dilated pupils\n* Abbreviated Injury Scale score \\> 5 for any body part except brain\n* Severe pre-existing chronic disease\n* Uncontrolled hypertension, defined as mean arterial pressure \\> 130mmHg despite antihypertensive treatment\n* Known hypersensitivity to mammalian cell-derived products or human albumin\n* Currently taking anticoagulants","healthyVolunteers":false,"sex":"ALL","minimumAge":"15 Years","stdAges":["CHILD","ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Glasgow Outcome Scale","description":"Dichotomized to favorable outcome (good recovery or moderate disability) or to unfavorable outcome (severe disability or vegetative or dead)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"17","spread":null},{"groupId":"OG001","value":"17","spread":null},{"groupId":"OG002","value":"34","spread":null},{"groupId":"OG003","value":"37","spread":null},{"groupId":"OG004","value":"31","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"18","spread":null},{"groupId":"OG001","value":"40","spread":null},{"groupId":"OG002","value":"55","spread":null},{"groupId":"OG003","value":"50","spread":null},{"groupId":"OG004","value":"63","spread":null}]}]}]},{"type":"SECONDARY","title":"Disability Rating Scale","description":"Disability rating scale was a secondary outcome measure for the transfusion threshold analysis. Disability rating scale ranges from 0 to 30, with 30 indicating death and 0 indicating return to normal status.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5","spread":null},{"groupId":"OG001","value":"8","spread":null}]}]}]},{"type":"SECONDARY","title":"Mortality Rate","description":"mortality rate was a secondary outcome measure for the Epo randomization, and a primary safety outcome measure for the transfusion threshold randomization","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6","spread":null},{"groupId":"OG001","value":"7","spread":null},{"groupId":"OG002","value":"18","spread":null},{"groupId":"OG003","value":"14","spread":null},{"groupId":"OG004","value":"17","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"32","spread":null},{"groupId":"OG001","value":"57","spread":null},{"groupId":"OG002","value":"80","spread":null},{"groupId":"OG003","value":"85","spread":null},{"groupId":"OG004","value":"84","spread":null}]}]}]},{"type":"SECONDARY","title":"Incidence of Adult Respiratory Distress Syndrome (ARDS)","description":"development of ARDS was a primary safety outcome for the transfusion threshold randomization","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"16","spread":null},{"groupId":"OG001","value":"25","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"83","spread":null},{"groupId":"OG001","value":"76","spread":null}]}]}]},{"type":"SECONDARY","title":"Incidence of Infection","description":"occurrence of infection was a primary safety outcome for the transfusion threshold randomization","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"27","spread":null},{"groupId":"OG001","value":"36","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"72","spread":null},{"groupId":"OG001","value":"65","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":29,"n":38},"commonTop":["Anemia","Other hematologic disorder","Electrolyte imbalance","Elevated transaminases","Atelectasis"]}}}